1-4 of 4
Mark Cannon
Close
Sort by
Journal Articles

Post-Transplant Donor Lymphocyte Infusion with Methotrexate Prophylaxis Is Associated with Low Incidence of Relapse after CD34-Selected, T Cell-Depleted Haploidentical Donor Stem Cell Transplantation Regardless of NK Alloreactivity

Michael J Eckrich, MD MPH, Stacy Epstein, PharmD, Carrie Barnhart, RN, Javier Oesterheld, MD, Darci Grochowski, PA, Mark Cannon, BA, Andrew L Gilman, MD
Journal: Blood
Blood (2015) 126 (23): 3166.
https://doi.org/10.1182/blood.V126.23.3166.3166
Published: 2015
Journal Articles

CD34-Selected, T Cell-Depleted Alternative Donor Stem Cell Transplantation For Children

Andrew Gilman, Michael Eckrich, MD, Stacy Epstein, PharmD, Carrie Barnhart, RN, Javier Oesterheld, MD, Darci Grochowski, PA, Tracy Fukes, RN, Maria Lacaria, RN, Mark Cannon, BA
Journal: Blood
Blood (2013) 122 (21): 2064.
https://doi.org/10.1182/blood.V122.21.2064.2064
Published: 2013
Journal Articles

KSHV LANA inhibits TGF-β signaling through epigenetic silencing of the TGF-β type II receptor

Daniel L. Di Bartolo, Mark Cannon, Yi-Fang Liu, Rolf Renne, Amy Chadburn, Chris Boshoff, Ethel Cesarman
Journal: Blood
Blood (2008) 111 (9): 4731–4740.
https://doi.org/10.1182/blood-2007-09-110544
Published: 2008
Journal Articles

KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2

Mark Cannon, Ethel Cesarman, Chris Boshoff
Journal: Blood
Blood (2006) 107 (1): 277–284.
https://doi.org/10.1182/blood-2005-06-2350
Published: 2006